Parker VL - Search Results

1

High HIV prevalence in gestational trophoblastic neoplasia patients.

Parker VL, Baker ZLI, Stone BJ, Singh K, Winter MC, Palmer JE. Parker VL, et al. AIDS. 2024 Jan 1;38(1):69-73. doi: 10.1097/QAD.0000000000003738. Epub 2023 Oct 9. AIDS. 2024. PMID: 37816174

2

Classification systems in Gestational trophoblastic neoplasia - Sentiment or evidenced based?

Parker VL, Pacey AA, Palmer JE, Tidy JA, Winter MC, Hancock BW. Parker VL, et al. Cancer Treat Rev. 2017 May;56:47-57. doi: 10.1016/j.ctrv.2017.04.004. Epub 2017 Apr 13. Cancer Treat Rev. 2017. PMID: 28482228 Review.

3

Demographics, natural history and treatment outcomes of non-molar gestational choriocarcinoma: a UK population study.

Savage P, Winter M, Parker V, Harding V, Sita-Lumsden A, Fisher RA, Harvey R, Unsworth N, Sarwar N, Short D, Aguiar X, Tidy J, Hancock B, Coleman R, Seckl MJ. Savage P, et al. BJOG. 2020 Aug;127(9):1102-1107. doi: 10.1111/1471-0528.16202. Epub 2020 Apr 3. BJOG. 2020. PMID: 32146729

4

Computed tomography chest imaging offers no advantage over chest X-ray in the initial assessment of gestational trophoblastic neoplasia.

Parker VL, Winter MC, Whitby E, Parker WAE, Palmer JE, Tidy JA, Pacey AA, Hancock BW, Harrison RF. Parker VL, et al. Br J Cancer. 2021 Mar;124(6):1066-1071. doi: 10.1038/s41416-020-01206-8. Epub 2020 Dec 16. Br J Cancer. 2021. PMID: 33328608 Free PMC article.

5

PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?

Parker VL, Winter MC, Tidy JA, Hancock BW, Palmer JE, Sarwar N, Kaur B, McDonald K, Aguiar X, Singh K, Unsworth N, Jabbar I, Pacey AA, Harrison RF, Seckl MJ. Parker VL, et al. Int J Cancer. 2023 Mar 1;152(5):986-997. doi: 10.1002/ijc.34352. Epub 2022 Dec 3. Int J Cancer. 2023. PMID: 36346113 Free PMC article.

6

Flat-dose versus weight or body surface area-based methotrexate dosing in low-risk gestational trophoblastic neoplasia.

Parker VL, Cushen BF, Hills A, Kandiah K, Palmer JE, Singh K, Hancock BW, Tidy JA, Winter MC. Parker VL, et al. Gynecol Oncol. 2023 Feb;169:34-40. doi: 10.1016/j.ygyno.2022.11.025. Epub 2022 Dec 7. Gynecol Oncol. 2023. PMID: 36495594 Free article.

7

Factors associated with failed 'test of cure' in the NHS Cervical Screening Programme: A retrospective cohort study.

Long E, Macdonald MC, Parker VL, Lyon R, Ellis K, Palmer JE. Long E, et al. Among authors: parker vl. Gynecol Oncol. 2023 Dec;179:158-163. doi: 10.1016/j.ygyno.2023.10.022. Epub 2023 Nov 20. Gynecol Oncol. 2023. PMID: 37988947 Free article.

8

PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasia.

Parker VL, Winter MC, Tidy JA, Palmer JE, Sarwar N, Singh K, Aguiar X, Hancock BW, Pacey AA, Seckl MJ, Harrison RF. Parker VL, et al. Gynecol Oncol. 2024 Jan;180:152-159. doi: 10.1016/j.ygyno.2023.11.017. Epub 2023 Dec 12. Gynecol Oncol. 2024. PMID: 38091775 Free article.

9

Improving the quality of vascular surgical discharge planning in a hub centre.

Wariyapola C, Littlehales E, Abayasekara K, Fall D, Parker V, Hatton G. Wariyapola C, et al. Ann R Coll Surg Engl. 2016 Apr;98(4):275-9. doi: 10.1308/rcsann.2016.0093. Epub 2016 Feb 29. Ann R Coll Surg Engl. 2016. PMID: 26924480 Free PMC article.

10

Bladder ultrasonography for diagnosing detrusor overactivity: test accuracy study and economic evaluation.

Rachaneni S, McCooty S, Middleton LJ, Parker VL, Daniels JP, Coomarasamy A, Verghese TS, Balogun M, Goranitis I, Barton P, Roberts TE, Deeks JJ, Latthe P; Bladder Ultrasound Study (BUS) Collaborative Group. Rachaneni S, et al. Among authors: parker vl. Health Technol Assess. 2016 Jan;20(7):1-150. doi: 10.3310/hta20070. Health Technol Assess. 2016. PMID: 26806032 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page